XML 27 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net income $ 172,231 $ 104,998 $ 44,296
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 193,194 166,241 164,259
Long-lived and other asset impairment 10,681 12,041 21,442
Non-cash restructuring charges   221  
Unrealized change in fair value of investment in unconsolidated affiliate 1,484 973 1,864
Inventory write-downs 550 545 1,640
Amortization of operating lease right-of-use assets 3,852 3,319 3,206
Amortization of deferred financing costs 5,072 5,729 5,152
Amortization of debt premium (2,006) (2,006) (2,006)
Amortization of capitalized implementation costs 3,009 2,624 1,984
Amortization of dedesignated interest rate swap     410
Interest rate swaps     631
Debt extinguishment loss 3,181    
Stock-based compensation expense 14,646 12,998 11,928
Provision for credit losses 381 224 206
Gain on sale of assets, net (17,887) (10,199) (12,396)
Gain on sale of business     (28,098)
Deferred income tax provision 58,090 35,658 15,229
Amortization of contract costs 23,877 21,289 19,162
Deferred revenue recognized in earnings (15,001) (16,464) (20,956)
Changes in operating assets and liabilities:      
Accounts receivable, net 524 (9,123) (19,971)
Inventory (1,920) 4,189 (10,520)
Other assets (2,537) (1,895) (2,653)
Contract costs (23,902) (24,292) (29,575)
Accounts payable and other liabilities (15,850) (12,166) 13,529
Deferred revenue 18,052 15,386 24,642
Other (130) (103) 45
Net cash provided by operating activities 429,591 310,187 203,450
Cash flows from investing activities:      
Capital expenditures (359,032) (298,632) (239,867)
Proceeds from sale of business     99,611
Proceeds from sale of property, equipment and other assets 67,591 72,206 20,654
Proceeds from insurance and other settlements 45 1,222 3,353
Cash paid in TOPS Acquisition, net of cash acquired (866,170)    
Investments in unconsolidated entities (2,497) (7,287) (14,667)
Net cash used in investing activities (1,160,063) (232,491) (130,916)
Cash flows from financing activities:      
Borrowings of long-term debt 1,429,500 802,825 826,733
Repayments of long-term debt (1,308,200) (767,050) (809,983)
Proceeds from 2032 Notes offering 700,000    
Partial repayment of 2027 Notes (201,987)    
Payments of debt issuance costs (12,338) (6,031)  
Payments for settlement of interest rate swaps that include financing elements     (1,334)
Dividends paid to stockholders (110,374) (95,796) (90,315)
Repurchases of common stock (13,337) (8,860)  
Taxes paid related to net share settlement of equity awards (6,574) (3,829) (2,447)
Net proceeds from issuance of common stock 255,747   4,176
Proceeds from stock issued under ESPP 1,117 817 633
Net cash provided by (used in) financing activities 733,554 (77,924) (72,537)
Net increase (decrease) in cash and cash equivalents 3,082 (228) (3)
Cash and cash equivalents, beginning of period 1,338 1,566 1,569
Cash and cash equivalents, end of period 4,420 1,338 1,566
Supplemental disclosure of cash flow information:      
Interest paid 120,544 107,765 98,406
Supplemental disclosure of non-cash investing transactions:      
Accrued capital expenditures 19,742 $ 25,689 $ 9,899
Issuance of Archrock common stock pursuant to TOPS Acquisition $ 139,054